1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Abalonex, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury ABX-101 1mg, ABX-101 2mg - Traumatic Brain Injury, Cerebral Edema | Phase 2 | Unknown | Abalonex, LLC | 45 | 2023-12-01 | 2023-10-23 |
Brain Edema (1) · Brain Injuries, Traumatic (1)